Prostaglandin-mediated control of rat brain kynurenic acid synthesis - Opposite actions by COX-1 and COX-2 isoforms

Journal of Neural Transmission

Volumn 112, Issue 7, 2005, Pages 863-872

  Schwieler, L ^a   Erhardt, S ^a   Erhardt, C ^a   Engberg, G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Diclofenac; Indomethacin; Ketorolac; Kynurenine; Meloxicam; Misoprostol; Nociception; NSAID; Paracetamol; Parecoxib; Psychoses; Schizophrenia

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; INDOMETACIN; KETOROLAC; KYNURENIC ACID; MELOXICAM; MISOPROSTOL; PARECOXIB; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; ENZYME ACTIVITY; MALE; MENTAL DISEASE; MOLECULAR DYNAMICS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; BRAIN; DICLOFENAC; ENZYME INHIBITORS; INDOMETHACIN; ISOXAZOLES; KYNURENIC ACID; MALE; PROSTAGLANDINS; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; THIAZINES; THIAZOLES;

EID: 20944441781     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0231-y     Document Type: Article

References (50)

1. Birch PJ, Grossman CJ, Hayes AG (1988) Kynurenic acid antagonizes responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 154: 85-87
2. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15: 339-343
3. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal, subjects, patient groups, and pharmacological studies. Psychopharmacol 156: 234-258
4. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99: 13926-13931
5. Clunie M, Crone LA, Klassen L, Yip R (2003) Psychiatric side effects of indomethacin in parturients. Can J Anaesth 50: 586-588
6. Dickenson AH, Aydar E (1991) Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat. Neurosci Lett 121: 263-266
7. Dickenson AH, Chapman V, Green GM (1997) The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol 28: 633-638
8. Domino EF, Luby E (1981) Abnormal mental states induced by phencyclidine as a model of schizophrenia. In: Domino EF (ed) PCP (Phencyclidine): historical and current perspectives. NPP Books, Ann Arbor
9. Edwards SR, Mather LE, Lin Y, Power I, Cousins MJ (2000) Glutamate and kynurenate in the rat central nervous system following treatments with tail ischaemia or diclofenac. J Pharm Pharmacol 52: 59-66
10. Engelhardt G, Bogel R, Schnitzler C, Utzmann R (1996) Meloxicam: influence on arachidonic acid metabolism, part II. In vivo findings. Biochem Pharmacol 51: 29-38
11. Erhardt S, Engberg G (2002) Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid. Acta Physiol Scand 175: 45-53
12. Erhardt S, Oberg H, Mathe JM, Engberg G (2001a) Pharmacological elevation of endogenous kynurenic acid levels activates nigral dopamine neurons. Amino Acids 20: 353-362
13. Erhardt S, Blennow K, Nordin C, Skogh E, Lindstrom LH, Engberg G (2001b) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313: 96-98
14. Erhardt S, Schwieler L, Engberg G (2002) Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine. Synapse 43: 227-237
15. Erhardt S, Schwieler L, Emanuelsson C, Geyer M (2004) Endogenous kynurenic acid disrupts prepulse inhibition. Biol Psychiatry 56: 255-260
16. Euchenhofer C, Maihofner C, Brune K, Tegeder I, Geisslinger G (1998) Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci Lett 248: 25-28
17. Franzone JS, Cravanzola C, Reboani MC (1980) Influence of non-steroidal anti-inflammatory compounds on the hepatic tryptophan pyrrolase activity in hypo- and hyperthyroid rats. Arch Int Pharmacodyn Ther 245: 156-165
18. Fundytus ME (2001) Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs 15: 29-58
19. Hajos M, Engberg G (1990a) Kynurenic acid blocks chemogenic nociception. J Pharm Pharmacol 42: 373-374
20. Hajos M, Engberg G (1990b) A role of excitatory amino acids in the activation of locus coeruleus neurons following cutaneous thermal stimuli. Brain Res 521: 325-328
21. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21: 7463-7473
22. Hoppmann RA, Peden JG, Ober SK (1991) Central nervous system side effects of nonsteroidal anti-inflammatory drugs. Aseptic meningitis, psychosis, and cognitive dysfunction. Arch Int Med 151: 1309-1313
23. Jentsch JD, Roth RH (1999) The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20: 201-225
24. Jett MF, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T, Sun T, O'Yang C, Hunter JC, Eglen RM, Johnson RM (1999) Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther 288: 1288-1297
25. Jiang HK, Chang DM (1999) Non-steroidal anti-inflammatory drugs with adverse psychiatric reactions: five case reports. Clin Rheumatol 18: 339-345
26. Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52: 1319-1328
27. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelly R (1959) Study of a new schizophrenomimetic drug - Seernyl. AMA Arch Neurol Psychiatry 81: 363-369
28. Martinez RV, Reval M, Campos MD, Terron JA, Dominguez R, Lopez-Munoz FJ (2002) Involvement of peripheral cyclooxygenase-1 and cyclooxygenase-2 in inflammatory pain. J Pharm Pharmacol 54: 405-412
29. Mazario J, Gaitan G, Herrero JF (2001) Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology 40: 937-946
30. McCormack K (1994) The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs 47: 28-45
31. Mengle-Gaw LJ, Schwartz BD (2002) Cyclooxygenase-2 inhibitors: promise or peril? Mediators Inflamm 11: 275-286
32. Müller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K, Ulmschneider M, Engel RR, Moller HJ, Schwarz MJ (2002) Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 159: 1029-1034
33. Nässtrom J, Karlsson U, Post C (1992) Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice. Eur J Pharmacol 212: 21-29
34. Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg C, Baran L, Przegalinski E, Kostowski W, Krzascik P, Chizh B, Headley PM (1997) Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. J Pharmacol Exp Ther 283: 1264-1275
35. Scharfman HE, Goodman JH, Schwarcz R (2000) Electrophysiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro. Amino Acids 19: 283-297
36. Schwarcz R, Du F, McCarthy KE, Okuno E, Roberts RC (1992) Immunohistochemical localization of 3-hydroxyanthranilic acid oxygenase (3HAO) and kynurenine aminotransferase in astrocytes in the rat substantia nigra. Soc Neurosci Abstr 18: 437-513
37. Schwarcz R, Rassoulpour A, Wu HQ, Medoff D, Tamminga CA, Roberts RC (2001) Increased cortical kynurenate content in schizophrenia. Biol Psychiatry 50: 521-530
38. Schwieler L, Erhardt S (2003) Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid. Neuropsychopharmacology 28: 1770-1777
39. Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69: 145-182
40. Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45: 309-379
41. Svensson CI, Yaksh TL (2002) The spinal phospholipase-cyclooxygenase- prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 42: 553-583
42. Talley JJ, Bertenshaw SR, Brown DL, Carter JS, Graneto MJ, Kellogg MS, Koboldt CM, Yuan J, Zhang YY, Seibert K (2000) N-[[(5-methyl-3-phenylisoxazol-4- yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: a potent and selective inhibitor of COX-2 for parenteral administration. J Med Chem 43: 1661-1663
43. Tegeder I, Niederberger E, Vetter G, Brautigam L, Geisslinger G (2000) Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord. J Neurochem 79: 777-786
44. Tharumaratnam D, Bashford S, Khan SA (2000) Indomethacin induced psychosis. Postgrad Med J 76: 736-737
45. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231: 232-235
46. Wallace JL, McKnight W, Reuter BK, Vergnolle N (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119: 706-714
47. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96: 7563-7568
48. Woolf CJ, Thompson SW (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 44: 293-299
49. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386
50. Zhang YQ, Ji GC, Wu GC, Zhao ZQ (2003) Kynurenic acid enhances electroacupuncture analgesia in normal and carrageenan-injected rats. Brain Res 966: 300-307